Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.

Clinical trial NCT04682444 · COMPLETED

Trial details

NCT number: NCT04682444
Sponsor: Joint Stock Company "Farmak"
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Respiratory Viral Infections Human Influenza

Start date: 2009-04-13
Primary completion: 2010-01-15
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.